Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Yiling Pharma Climbs in Post-IPO Trading

publication date: Jul 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shares of Shijiazhuang Yiling Pharmaceutical climbed 27% following the company’s IPO on the ChiNext exchange. As we reported last week, the company, which makes cardiovascular and cerebrovascular medicines, bumped the price of its IPO higher by one-third due to higher-than-expected demand, raising the value of the transaction to 2.25 billion RMB ($348 million). Even after the price increase, investors still bid the shares up when they began trading. More details....

Stock Symbol: (SHE: 002603)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners